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Currently, there are few studies separating the linkage of pathological obese and over-
weight body mass indices (BMIs) to the all-cause mortality rate in adults. Consequently, 
this paper, using annual Behavioral Risk Factor Surveillance System data of the 50 US 
states and the District of Columbia, estimates empirical regression models linking the 
US adult overweight (25 ≤ BMI <  30) and obesity (BMI ≥  30) rates to the all-cause 
deaths rate. The biochemistry of multi-period cumulative adiposity (saturated fatty acid) 
from unexpended caloric intakes (net energy storage) provides the natural theoretical 
foundation for tracing unhealthy BMI to all-cause mortality. Cross-sectional and panel 
data regression models are separately estimated for the delayed effects of obese and 
overweight BMIs on the all-cause mortality rate. Controlling for the independent effects 
of economic, socio-demographic, and other factors on the all-cause mortality rate, our 
findings confirm that the estimated panel data models are more appropriate. The panel 
data regression results reveal that the obesity-mortality link strengthens significantly after 
multiple years in the condition. The faster mortality response to obesity detected here is 
conjectured to arise from the significantly more obese. Compared with past studies pos-
tulating a static (rather than delayed) effects, the statistically significant lagged effects of 
adult population BMI pathology in this study are novel and insightful. And, as expected, 
these lagged effects are more severe in the obese than overweight population segment. 
Public health policy implications of this social science study findings agree with those of 
the clinical sciences literature advocating timely lifestyle modification interventions (e.g., 
smoking cessation) to slow premature mortality linked with unhealthy BMIs.
Keywords: obesity, body mass index, overweight, all-cause mortality rate
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inTrODUcTiOn
Obese and overweight conditions are unhealthy for individuals and populations. Pathological 
body mass indices (BMIs) incubate complex sets of serious diseases, which lead to job absences 
and atrophied labor productivities (1), various disabilities, and all-cause mortalities in the U.S. (2) 
and globally. Specifically, the obesity syndrome poses major public health and policy challenges in 
high growth economies (e.g., China), Eastern European transition countries, and developing nations 
(3, 4). Moreover, obesity is comorbid with mental health conditions (5, 6), subclinical myocardial 
injury and heart failure (7), and other diseases. As a result, the medical personnel, public health 
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policy makers, and global health bodies (e.g., The WHO) argue 
that the obesity epidemic and its premature mortality and socio-
economic burdens are problematic. Interestingly, obesity is an 
officially certified mortality cause on 25% of the 1979–2006 death 
certificates in England (8). The US adult obesity prevalence rate 
rose from 12.7% during 1959–1962 to 29.6% in 1999–2000 (9), 
and remained constant for the periods 2003–2004 and 2011–2012 
(10). The National Institutes of Health (11) declared overweight 
and obesity the second leading causes of preventable deaths fol-
lowing tobacco.
Obesity, an indicator of biological welfare, is defined as having 
a weight more than 20% above the ideal for a person. Clinically, 
obesity defines an excessively high amount of body fat or adipos-
ity relative to lean muscle body mass. BMI, a frequently used 
but imperfect measure of obesity (12), is adult body weight in 
kilograms divided by height squared in meters. The currently 
established levels of BMI are: normal is BMI 18.5 ≤ BMI ≤ 24.9; 
overweight is 25 ≤ BMI ≤ 29.9; and obese is BMI ≥ 30. More 
than 80% of the estimated obesity-attributable deaths occur in 
those with a BMI greater than 30 (13). Heart diseases, cancer, 
and stroke, the three leading causes of US deaths [(14), p. 58], are 
positively correlated with significant overweight and obese BMIs. 
The economic and other costs of U.S. obesity are high. The direct 
health care cost estimates would be 25% lower when one accounts 
for differential mortality of the obese (15). In 1998, for example, 
the medical cost of obesity was estimated at $78.5 billion and 
the increased obesity prevalence was responsible for some $40 
billion in higher medical cost through 2006, including $7 billion 
in Medicare prescription drug costs (16).
Currently, separate econometric model estimates of the 
time-phased transition of the overweight or obese conditions 
to mortality do not exist in the literature. Consequently, this 
study goal is to control for a large number of other independent 
effects, broaden the linkage of obesity beyond specific diseases, 
and econometrically isolate the robust effects of unhealthy body 
masses, measured by BMI levels of overweight and obese, on 
the all-cause mortality rate. Modeling their independent effects 
is crucial for their linkage to life expectancy as the all-cause 
mortality rate is a key measure of population health. Our study 
uses state-level annual data of the 50 US states and the District 
of Columbia (DC) to test the following statistical hypotheses. (1) 
Unhealthy BMIs are positively and significantly linked to the all-
cause mortality rate; (2) the obese mortality impact is numerically 
greater than that of overweight; and (3) there are delayed effects 
of unhealthy BMIs on the all-cause mortality rate.
Section 2 focuses on literature review, the theoretical frame-
work, empirical models for statistical estimation, and the data 
description. Section 3 covers the empirical regression results. 
The concluding section 4 discusses the findings and implications.
MeThODs: TheOrY, MODel,  
anD The DaTa
Drawing from received theories in medicine and the allied 
health sciences, Lee and Skerrett (17) proposed an inverse 
linear dose–response link of physical activity volume (intensity, 
duration, frequency) to all-cause mortality rates, regardless of 
gender or age. More precisely, some physical activity guidelines 
mandating an energy expenditure of about 4200  kJU  week−1 
yields a significant 20–30% reduction in all-cause mortality risk 
(17). This suggests that lacking adherence to minimal physical 
activity guidelines, resulting in an unhealthy BMI, raises risk for 
all-cause mortality rate (i.e., change in mortality from a given 
change in obesity prevalence rate is theoretically expected to be 
positive). Another theory linking lifetime expenditure of energy 
per gram of tissue to body mass posits that tissue in smaller ani-
mals expends more energy before expiring than tissue in larger 
animals, and smaller individuals with higher rates of metabolism 
live longer than their slower and larger counterparts (18). Ervin 
(19) reports a U-shaped relationship between BMI and mortality, 
with the greatest risks in the extremes of the lowest and highest 
ranges.
The risk of all-cause mortality also rises with relative depriva-
tion (20); that is, a greater sense of deprivation perceived by the 
poor relative to their well-off reference group leads to greater 
odds of ill health, disability, and all-cause mortality that are also 
potentially attributable to lack of quality health care access. The 
Gini income inequality measure is here used to proxy relative 
deprivation for the impoverished. Therefore, the a priori expected 
sign of the change in all-cause mortality due to wider income 
inequalities is positive because limited access of the poor to qual-
ity health care raises mortality risks.
Standard models of health production based on mortality 
rates incorporate education or schooling years as a factor (21). 
The better educated takes the long view in health care decision 
making. Therefore, the less than high school education dummy 
variable (LHS) is a priori expected to be associated with greater 
mortality (MORT) compared to the more educated high school or 
GED completion, post high school, and 4-year or higher college 
completion. Since income and education are highly correlated, 
the standard income measure is excluded from our model to 
avoid severe multi-collinearity. However, to capture resource 
constraints as a correlate of all-cause deaths, the population 
proportion below the US Federal Poverty Level (FEDPVTY) 
is included to test whether indigent population status (income 
proxy) is positively related to mortality.
Ng-Mak et  al. (22) found black persons younger than 
65 years to be at higher risk than others for all-cause and car-
diovascular deaths. Consequently, in relation to the non-whites 
group, the population percent of whites (WHITE) is expected 
to be negatively associated with the all-cause mortality rate, 
all else equal. Moreover, all-cause mortality rate naturally 
tends to rise as the population ages due to general biological 
or soma deterioration.1 The aging effect of population percent 
≤65  years (POPLT65), used here to proxy the correlation 
of aging structure with deaths, is expected to be negative. 
Moreover, the crude birth rate (CBRATE) is included as a 
distinct demographic dimension to compensate for the use of 
1 Human genetics literature claims that small pieces of the telomere (compound 
structure at the end of a chromosome) are lost during each cycle of human DNA 
replication. Sequential shortening of telomere length, which can speed up through 
oxidative stress, is a known biomarker of ageing. 
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all-cause crude mortality rate, rather than standardized death 
rate, as the dependent variable. (One major concern when 
using gender- or age-adjusted death rates for the US states for 
multiple time periods is that standardized rates for different 
time periods cannot be compared because they were adjusted 
by different standard populations. Moreover, consistent data 
for each state and the DC for are unavailable.) The a  priori 
sign expected of the crude birth rate in the mortality model is 
positive. Finally on demographics, life expectancy at birth and 
longevity of females tend to be higher than for males at similar 
age (23), for reasons, including but not limited to lifestyle risks 
and biological factors. Theoretically, the effect on mortality 
due to a change in female population proportion (FEMALE) is 
expected to be negative in our model.
Acute air pollution is a major driver of mortality (24). The envi-
ronmental hazards in urban areas raise morbidity and mortality 
rates (25). The theoretical sign of urbanization (URBPOP) in the 
mortality model could be ambiguous, as urban areas contain both 
greater health hazard risks and greater concentrations and varie-
ties of general, specialized surgical, and emergency care facilities 
benefiting from multiple sources of cost economies [(26), p. 83] 
to achieve greater efficiencies and quality of healthcare outcomes. 
Moreover, greater population exposure to the multiplicity of aerial 
gaseous, water, and solid pollutants (27) suggests that toxic waste 
concentrations are likely to be associated with greater all-cause 
mortality rates, a priori. Therefore, the number of solid waste sites 
per square mile of a US state area (TOXIC), exposing humans 
to ill health conditions, is here proposed to also raise all-cause 
population mortality risks.
Kromhout et al. (28) infer that a 5% reduction in saturated fat 
consumption, an increase of 20 mg/day consumption of vitamin 
C and a 10% reduction in smoking could cut the all-cause mor-
tality rate by 12.4%. Therefore, smoking cessation and reduced 
tobacco use (SMOKE) would cut the all-cause death rate. Finally, 
due to some (unmeasured) permanent heterogeneous factors 
specific to each region, the differential effects of pathological 
conditions occurring in the US geographic regions are captured 
using regional dummies.
Our theoretical postulations together with those already 
established in the reviewed literature lead us to propose the fol-
lowing model for empirical econometric estimation:
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where the Greek symbols with specific regressors are the regres-
sion parameters to be estimated and ξ is the error term. The first 
regression model experiment has no lag effects for OBES and 
OWT, the second incorporates a one-period lag each for OBES 
and OWT, the third is a two-period lag model each for OBES 
and OWT, and the fourth model contains three-period lags of the 
pathological weight indices. The sequential lagging enables us to 
gain clearer insights into how increased lag lengths of unhealthy 
BMI ranges impact on current all-cause MORT rate.
The regression model was fitted to the data of 50 U.S. states and 
DC, taken from the Behavioral Risk Factor Surveillance System 
(BRFSS) database (29) for the 4 years 2000–2001–2002–2003 for 
which the BMI data are consistently reported. This study period 
is notably interesting from an historical perspective because, 
compared with the 1960–1962 period, the U.S. adult (ages 
20 years and above) obesity prevalence rate rose the fastest and 
almost doubled in the 1988–1994 period. Coincidentally, the U.S. 
population diagnosed with diabetes rose the fastest and almost 
doubled from 8.7 million in 1995 to 8.7 million in 2005 (30). The 
dataset (Overview: BRFSS, 2006) is a collaborative project of the 
Centers for Disease Control and Prevention (CDC) and all U.S. 
states and territories (31). The objective of the BRFSS is to gather 
uniform, state-specific data on preventive health practices and risk 
behaviors, including weight factors, which are linked to chronic 
diseases, injuries, and preventable infectious diseases. The BRFSS 
employs telephone survey data collected from a random sample 
of adults by each state to measure behavioral risk factors in the 
adult population (age ≥18) living in households.
The dependent variable (MORT) is all-cause mortality per 
100,000 of the adult resident population in each US state and 
the DC. All-cause mortality data are from the US Census Bureau 
(32). Separate cross-sectional annual, and panel regression 
models are estimated linking all-cause mortality per 100,000 of 
the population to “overweight” (25 ≤ BMI ≤ 29.9), and “obese” 
(BMI ≥  30) adult BMI values with controls for a set of other 
effects (e.g., formal education, urbanization rate, density of toxic 
waste sites, etc.,). We estimate the distributed lag effects of obesity 
and overweight on the all-cause mortality in order to trace the 
shape of their time-phase. Separate cross-sectional regression 
models of the BMI effects (OWT, OBES) on all-cause mortality 
are studied for each year, and for the panel of years. Our panel 
estimates would be tenable if population migration is slow across 
the states.
The population percent overweight (OWT) and obese (OBES) 
are the independent variables of core interest in this study. The 
other independent variables as controls, obtained from the BRFSS 
data, unless otherwise noted, include the GINI income inequal-
ity measure for each state (the Gini is an economic measure of 
deviation from equal income distribution with a 0–1value range); 
education level (LHS is less than high school, HS is high school 
completion or GED equivalent, PHS is post high school COLLG 
is 4-year college completion); and SMOKE is percent of cigarette 
smokers in each state. State specific data on crude birth rates 
(CBRATE) are from the National Vital Statistics Reports (33). The 
TOXIC variable is computed as the number of US Environmental 
Protection Agency (34) designated toxic waste sites per square 
mile area of each state (US Environmental Protection Agency, 
2006). Finally, URBPOP is the percent of urban population, and 
the US geographic region dummies (Midwest, Northeast, and 
West, relative to the South) control for heterogeneous, permanent 
regional factors that differentially correlate with all-cause MORT. 
The base case represents normal weight, less than high school 
education, non-smoker, male gender, population 65 years of age 
and older, non-white, and the South region.
Table 1 | Descriptive statistics of the panel data.
Variable Definition Mean sD
MORT Mortality per 100,000 by state 44.31373
Source: US Bureau of the Census, 2006
OWT 25 ≤ Body Mass Index < 30 36.8087 1.3022
Source: Behavioral Risk Factor Surveillance System (BRFSS), Centers for Disease Control 
and Prevention (CDC), 2004
CBRATE Crude birth rate per 1,000 population 13.8997 1.1298
Source: National Vital Statistics Reports (CDC)
OBES Body Mass Index ≥30 21.3367 2.3897
Source: BRFSS (CDC), 2004
GINI Gini coefficient of income inequality 0.4485 0.026
Source: BRFSS (CDC), 2004
HS Population percent completing high school 31.9161 4.1479
Source: BRFSS (CDC), 2004
PHS Percent of population completing post high school 27.6626 3.3533
Source: BRFSS (CDC), 2004
COLLG Percentage of population completing 4-year college or higher 29.1729 5.4428
Source: BRFSS (CDC), 2004
SMOKE Percent of population smoking tobacco 22.9729 3.0149
Source: BRFSS (CDC), 2004
TOXIC Superfund toxic waste sites per square mile of the geographic land area of state 130.256 270.0375
Source: Environmental Protection Agency, 2006
FEMALE Population percent female 51.0002 0.725
Source: US Census Bureau, Population Estimates Program (PEP), 2007
WHITE Ethnic White population percent 17.872 13.44
Source: US Census Bureau (PEP), 2007
POPLT65 Population percent age 65 years and less 87.28 1.807
Source: US Census Bureau (PEP), 2007
FEDPVTY Population percent below Federal poverty (PEP), 2007  12.82 3.20
Source: US Census Bureau
URBPOP Population percent urbanized 71.797 14.9195
Source: BRFSS (CDC), 2004
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eMPirical regressiOn MODel 
resUlTs
Table 1 contains descriptive statistics of the study data. Cross-
sectional data OLS regression models performed for each year 
had few significant coefficient estimates, high R2 values of around 
80% that are statistically significant (high F statistics) and, as 
expected of cross-sectional annual models, heteroskedastic errors 
detected using the White (35) general test (significant χ2s values 
at α = 0.05 level). These suggest that some distributed lag model 
structure would represent an improved estimation strategy, given 
the moderate collinearity. Moreover, while the least squares esti-
mators are unbiased under heteroskedasticity, they are inefficient 
and the biased estimation of the variances invalidates statistical 
significance tests.
The cross-sectional models were re-estimated using the White 
(35) heteroskedasticity-consistent covariance matrix estimator. 
The cross-sectional regression estimates suggest that a theoreti-
cally more optimal specification of the separate impacts of being 
obese and overweight on the all-cause mortality rate ought to 
account for some delayed effects of unhealthy BMIs (cumulative 
net energy balance for multiple time periods).
Table 2 contains the estimated generalized least squares (EGLS 
or cross-sectional weighted least squares) regression model results 
for the four model experiments. The panel data estimates for the 
years 2000 through 2003 across the 50 states and the DC (model I) 
and three variants for the subsequent years, models II (state-level 
data years 2001–2003), III (state-level data years 2002–2003), and 
IV (state-level data years 2000–2003) are presented.
The regression estimates in model I include current period 
OWT and OBES variables; model II estimation incorporates 
1-period lag for variables OBES and OWT; model III includes 
2-period lags, and Model IV estimates include 3-period lags. The 
reported model fit summary statistics are weighted. The adjusted 
R2 values of the fitted models in this context range from 95.12% 
(for the no lag Model I) to 99.89% (for the 3-period lag model 
IV) based on panel data sets. The resulting adjusted R2 of 97.14% 
across the models in Table 2 signals that the models in general 
possess several desirable attributes. First, the regression fit of the 
panel data models (97.905%) is far superior to those of the (mis-
specified and, thus, not reported) cross-sectional models (80.0%). 
Second, from practical statistical modeling stance, any attempt to 
incorporate interaction effects as additional regressors can only 
very marginally, if at all, raise the panel data model fit by 2.09% 
since that the maximum bound of the R2 measure of any model 
fit is 1. Therefore, taken together, our estimated regression model 
fit to the observed panel data is quite good. Moreover, the EGLS 
regression estimator for this study is in general asymptotically 
Table 2 | Panel data egls regression model estimates of the determinants of Us mortality rate.
Model i (4 years panel  
data, no lag)
ii (4 years panel data, 
lagged 1 year)
iii (4 years panel data, 
lagged 2 years)
iV (4 years panel data, 
lagged 3 years)
Variable label independent Variable regression Model Parameter estimates
C Constant 2.0839 18.6557 −5.7236 10.7347**
OWTt Overweight in current year 2.3996a*** 3.7804*** 5.7783*** 0.9619
OWTt−1 Overweight lagged 1 year −0.3921 3.4297** −0.1448
OWTt−2 Overweight lagged 2 years 1.0457 −1.3214
OWTt−3 Overweight lagged 3 years 3.7878**
OBESt Obesity in current year 2.1941*** 2.2607*** 1.6656*** 1.2056**
OBESt−1 Obesity lagged 1 year 0.5757** 0.3498 0.1560
OBESt−2 Obesity lagged 2 years −0.4233 2.5163***
OBESt−3 Obesity lagged 3 years 0.6870***
CRDBRATE Crude birth rate 0.3771 0.5368** 0.1691 0.2930***
GINI Income inequality 2.9782a*** 3.2623*** 4.7267*** 0.6220
HS High school completion −2.6522*** −1.9520*** 0.5884 −0.1281
PHS Post high school −0.7805* −0.8852** 1.0797** −0.2003***
COLLG 4-year college degree or higher −1.5007*** −2.0119*** −2.4399 −1.5983*
SMOKE Cigarette smoking  0.7475 0.7598** 0.8989** 1.9810***
URBPOP Urban population percent 2.4949*** 2.6227*** 2.8615*** −0.1746
TOXIC Density of toxic waste sites 0.3037*** 0.4280*** 0.3201*** 0.3005***
FEMALE Female gender 1.6600 −3.5550 −4.7251 −2.3117***
POPLT65 Population age 65 and younger −4.5355*** −6.0969*** −8.2056*** −1.4093
WHITE White population percent  0.9116*** 1.1199*** 1.1788*** −0.6217
MIDWESTb IL, IA, IN, KS, MI, MN, MO, NE,  
ND, OH, SD, WI
−0.0028 −0.0497 −0.4290* −1.2495***
NORTHEAST CT, DE, DC, ME, MD, MA, NH,  
NJ, NY, PA, RI, VT
−1.0069** −1.0199*** −1.0962** −1.5635***
WEST AK, AZ, CA, CO, HI, ID, MT,  
NV, NM, OR, UT, WA
−0.01621 0.0523 0.1197 −0.1892***
Weighted Adjusted R2 0.9512 0.924 0.937 0.98
Weighted SE of Regression 0.6065 0.6101 0.5739 0.2703
Number of (year × state) Observations 204 153 102 51
aThe symbols ***, **, and * signify parameter estimate statistical significance, respectively, at the 10, 5, and 1% levels.
bSouth (comprising the states of FL, GA, NC, SC, VA, WV, AL, KY, MS, TN, AR, LA, and OK) is the base region. States within each US region are, respectively, abbreviated in 
column 2 of this table.
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more efficient than the classic ordinary least squares (OLS) 
estimator. The discussions below focus on the panel data models 
I (with no lags) through IV (with sequential lags) and justifies 
selection of model IV (with three-period lags each for OWT and 
OBES) as the optimal.
Current period OWT health state, as a priori expected, has a 
positive (models I–IV) and significant (models I–III) association 
with current mortality MORT (inverse health). Perhaps more 
importantly, the positive coefficient estimates of current year 
OBES across models I–IV are correctly signed and highly statisti-
cally significant throughout. In effect, the appropriately signed 
current OWT and OBES coefficient estimates reinforce confidence 
in their robustness as important correlates of all-cause deaths. 
Moreover, one- and three-period lagged OWT effects are positive 
and significant only in models III and IV. The mortality effects 
of one- to two-period lag OBES are even stronger: one-period 
lag OBES are correctly signed (models II–IV) and statistically 
significant (model II), two-period lag OBES are correctly signed 
(models II–IV) and significant (model IV), and three-period lag 
OBES effect is both highly significant and correctly signed (model 
IV). These findings suggest that a consistent history of obesity, 
more than overweight, tends to be associated with the current 
period mortality rates, ceteris paribus.
DiscUssiOn
Our empirical regression results on OBES as a strong correlate of 
all-cause deaths is consistent with received theories in the social 
sciences and medicine, namely that untreated pathological BMI 
states gradually lead to terminal health state (mortality). This is a 
significant and novel finding of our study on the obesity-mortality 
link using panel data of the US states and the DC.
The hypothesis that reduced access of the poor to health care, 
captured using the GINI income inequality distribution proxy 
is positively associated with all-cause deaths is correctly signed 
across the models and is highly significant. This evidence agrees 
with Cohen et al. (36) and Kahn, et al.’s (37) that high income 
inequality locations are associated with high all-cause mortality 
risk. Theoretically, the better educated tends to articulate health 
information more efficiently and takes a long time horizon in 
decision making on health capital formation. Relative to not 
completing high school (base category), more schooling (HS, 
6Okunade et al. Weight Pathology Effects on Mortality
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PHS, COLLG) is a priori expected to be inversely correlated with 
all-cause mortality – an hypothesis variously confirmed across 
panel data models (I, II and IV). Particularly, gradations of 
greater schooling years are associated with significantly reduced 
all-cause mortality rates for HS (models I and II), PHS (models I, 
II, and III), and for 4-year college or higher (models I, II, and IV) 
completion. The results are consistent with the negative associa-
tion of mortality and education in previous studies (38).
Smoking, a high-risk and an avoidable lifestyle habit, is here 
conjectured to be positively linked with all-cause mortality. The 
empirical regression coefficient estimates reported in Table  2 
for SMOKE in all the models support this assertion and they are 
statistically significant in models II through IV containing lagged 
pathological weight effects. Moreover, the ambient hazards in 
urban areas, URBPOP in general and TOXIC in particular perhaps 
also capturing lack of political voice of the poor or environmental 
discrimination, are positive and significant (in models I–III for 
URBPOP and in models I–IV for TOXIC) as theory predicts. 
Moreover, these estimates are broadly stable across specifications. 
Recall that the coefficient sign on the URBPOP was theoretically 
conjectured as indeterminate. Our empirical regression model 
estimates (Table 2) supports the theory that urban areas are health 
hazardous to humans in complex ways leading to the strongly 
positive correlation with all-cause deaths. This finding accords 
with the health economics literature in contrast to the strand of 
literature in industrial organization postulating that better health 
care facilities in urban areas raise health status.
Mortality rates tend to be associated with major demographic 
dimensions, such as age, gender, crude birth rate, and ethnicity. 
Our panel data model coefficient on ethnicity (WHITES) in 
model IV is correctly signed supports the general theory of lower 
all-cause mortality rate among the whites relative to other eth-
nicities the (base group). Consistent with the biological clinical 
evidence (39)2, the FEMALE gender dummy negatively associated 
with death rates suggests that men and women face significant 
differential mortality risks (40, 41). All-cause mortality is also 
relatively lower among the young (POPLT65), an effect that is 
uniformly correctly signed across the models (models I–IV) and 
significant in all but model IV. Finally, the all-cause mortality rate 
is highly significant and positively associated with the crude birth 
rate (CBRATE) in models II and IV.
The US regional controls (MIDWEST, NORTHEAST, WEST), 
relative to the South, suggests the presence of some highly signifi-
cant permanent regional heterogeneities in all-cause mortality. 
These findings reinforce the standard thinking that residents of 
non-Southern states benefit significantly from mortality reducing 
permanent geographic advantages.
The empirical results in model IV (based on 2003 state-level 
data and incorporating current period and lag lengths of one 
to three periods for each of OWT and OBES along with other 
determinants of all-cause mortality), relative to other models (see 
2 The US Centers for Disease Control and Prevention found women to outlive men 
an average of 5 years, and a new study (40) suggests that the disparity may originate 
from the loss of Y chromosome in blood cells prompting men to have shorter 
life spans and higher cancer mortality. Interestingly, epidemiological evidence, 
indicating some 95% of individuals living up to 110 years are females, is further 
reinforcing. 
Table 2), is optimal. Optimality of model IV is based on statistical 
fit (adjusted R2, etc) and consistency of the signs of the regression 
estimates with a priori theoretical expectations. Model IV results 
reinforce our initial conjecture that a model incorporating longer 
lag lengths is more appropriate for capturing the delayed effects of 
the BMI weight pathologies on the all-cause mortality rate.
Since income and education are typically correlated in health 
outcomes models, a proxy independent variable FEDPVTY was 
included as an indirect way for capturing the role of income while 
retaining education in the model. FEDPVTY surprisingly had a 
statistically significant negative association and so the models in 
Table 2 were re-estimated in its absence. Nevertheless, we present 
in Table A1 in Appendix (a variant of Model I) to illustrate the 
anomalous results with FEDPVTY included in Model I. Closer 
scrutiny suggests that the anomalous result in discussion does not 
derive from multi-collinearity of the FEDPVTY with any of the 
other determinants in the model. Moreover, comparing coefficient 
estimate of the TOXIC variable in Model I (Table 2), which excludes 
FEDPVTY, with that in Table A1 in Appendix, which includes 
FEDPVTY, shows the TOXIC variable is not picking up an omitted 
variable, such as poverty. In effect, the TOXIC parameter estimate is 
fairly robust (stable) across specifications (compare the numerical 
magnitudes and statistical significance of its estimates in Table 2 
with the one reported in Table A1 in Appendix incorporating 
FEDPVTY). Despite robustness of the estimated model parameters 
and good fit (i.e., adjusted R2 values) of the estimated models to the 
data in Table 2, indicating superiority relative to those in related 
past studies, the TOXIC measure may still be picking up the effect 
of some variable excluded from the mortality model in this study.
Several aspects of this research are innovative. First, is the use 
of lagged effects for the first, second, and third years for OWT and 
OBES, based on the time lags for the impact of weight pathol-
ogy on mortality. Under certain conditions, it is possible to infer 
patient-level relationships from aggregate data (42). Our finding 
significant the lagged effects of obesity on the all-cause mortality 
is consistent with clinical evidence from clinical medicine that 
Danish patients obese in early 20s increase heart disease risk and 
premature mortality at age 55 (43). Second, we separate over-
weight and obese to study their different effects on the all-cause 
mortality rate. Third, we estimate cross-sectional and pooled 
(panel) data models incorporating the delayed pathology weight 
effects on mortality. In conclusion, this research augmented rel-
evant multi-disciplinary theories and past research findings with 
novel insights to specify and estimate regression model parameters 
that link ranges of pathological BMIs (overweight, obese) to the 
all-cause mortality rate, for each cross-section year, and then for 
panel data models that included sequentially one-, two-, and three-
year cumulative lags of obesity and overweight BMI as regressors. 
Not surprisingly, and based on the optimal model IV in this study, 
current and multi-period lagged obesity as well as lagged 
overweight conditions, among other factors, are significantly 
associated with the current all-cause mortality rate. The panel 
data model estimates yield richer insights into the delayed, 
compounded effect of obesity, and overweight, on the all-cause 
deaths. The optimal model findings are robust and many important 
other covariates, e.g., smoking, toxic waste exposure, demograph-
ics, schooling, and regional location, are also correctly signed and 
significantly correlated with the all-cause mortality rate.
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Our study is based on data aggregated at the state level for the 
U.S. Therefore, to be consistent we focused literature review on 
studies based on aggregate data evidence. However, in agreement 
with one of the referees, it is important to also recognize related 
research findings from the Global Burden of Diseases (GBD) 
studies of individual-level data across countries. The Global BMI 
Mortality Collaboration (44) published recent findings on BMI 
and the all-cause mortality using individual-participant-data 
meta-analysis of 239 prospective studies on four continents (Asia, 
Australia and New Zealand, Europe, and North America). Their 
findings are that (1) all-cause mortality was minimal 20.0–25 kg/
m2 and it increased throughout the overweight range for BMI 
25.0– < 27.5 kg/m2 and BMI 27.5– < 30.0 kg/m2; and (2) for BMI 
>25 mortality increased approximately log-linearly with BMI. 
The study concludes that the broadly consistent positive asso-
ciation of overweight and obesity with higher all-cause mortality 
across continents align with various strategies instituted to arrest 
unhealthy BMI in many populations.
Finally, our innovative paper has some limitations for rectifi-
cation in future studies. First, findings based on disease-specific 
mortality rates would tend to differ from those based on the all-
cause mortality rates investigated here. Therefore, future studies 
on the differential effects of obesity and overweight population 
health states on premature mortality rates should focus on spe-
cific diseases3 (45) more closely tied to pathological BMI (such 
as underweight, overweight, and stages I–IV obesity ranges). 
Second, future mortality rate models that incorporate specific 
obesity control policy interventions and use longer panel data-
sets capturing the latest observed data points could yield better 
insights on public policy effectiveness. Third, future work could 
also incorporate the lagged effects of underweight BMI pathology 
as additional determinant of all-cause mortality and empirically 
replicate the theoretical model specification first proposed here 
with the use of longer data panels from other countries to test the 
robustness of our findings. Finally, it would be interesting to test 
for the possible consistency of this aggregate data research find-
ings with the future research results from fitting the mortality rate 
models to less aggregated or finer data (e.g., individual, county, or 
regional) breakdowns.
KeY POinTs
•	 Obesity is increasingly viewed as a direct cause of mortality 
on official death certificates. In this paper, weight pathology 
in the adult population has statistically significant delayed 
3 The range of chronic diseases associated with early deaths from physical inactivity 
include heart disease, stroke, type 2 diabetes, breast cancer, and colon cancer (45). 
effects that are spread over multiply years on the all-cause 
mortality rate.
•	 Controlling for a large number of potentially confounding 
factors, the delayed impacts of an unhealthy BMI on adult 
mortality rate are statistically significant for more years for the 
obese than the overweight.
•	 Our social science research findings reinforce implications 
from clinical evidence, that the effect of obesity on mortality 
can be successfully interrupted to avert premature deaths or 
slow the speed with which the obesity condition transits to 
terminal mortality.
•	 Our research findings reinforce the call for multipronged pri-
vate–public obesity management and control strategies aimed 
at a timely weakening of the obesity–mortality link.
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aPPenDiX
Table a1 | Panel data regression estimates of the determinants of Us 
mortality rate: an experiment incorporating FEDPVTY as an additional 
explanatory variable in the basic model.
independent variable Definition Parameter 
estimate
C Constant 63.67097***
OWTt Overweight in current year 5.940647***
OWTt−1 Overweight lagged 1 year
OWTt−2 Overweight lagged 2 years
OWTt−3 Overweight lagged 3 years
OBESt Obesity in current year 1.769509***
OBESt−1 Obesity lagged 1 year
OBESt−2 Obesity lagged 2 years 
OBESt−3 Obesity lagged 3 years
GINI Income Inequality 3.289570a***
HS High school completion –2.892221***
PHS Post high school –1.199448***
COLLG 4-year college degree –2.392919***
CRDBRATE
SMOKE Smoking 0.248608
URBPOP Urban population 1.943465***
COLLG 4-year college degree –2.392919***
TOXIC Density of toxic waste sites 0.420098***
FEMALE Female gender –12.62947***
POPLT65 Population age 65 and less –4.903563**
FEDPVTY Population below poverty –0.685718***
WHITE White 0.117149
MIDWESTb IL, IA, IN, KS, MI, MN, MO, NE, 
ND, OH, SD, WI
0.221689*
NORTHEAST CT, DE, DC, ME, MD, MA, NH, 
NJ, NY, PA, RI, VT
–0.933227a**
WEST AK, AZ, CA, CO, HI, ID, MT, NV, 
NM, OR, UT, WA
–0.0232445
Weighted adjusted R2 0.94
Weighted SE of regression 0.59
aThe symbols ***, *, and * signify parameter estimate statistical significance respectively 
at the 10, 5, and 1% levels.
bSouth region (FL, GA, NC, SC, VA, WV, AL, KY, MS, TN, AR, LA, and OK) is base. 
States in the regions are, respectively, listed in table column 2.
